Follow
pål klepstad
pål klepstad
Norwegian University of Technology and Science
Verified email at ntnu.no
Title
Cited by
Cited by
Year
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC
A Caraceni, G Hanks, S Kaasa, MI Bennett, C Brunelli, N Cherny, O Dale, ...
The lancet oncology 13 (2), e58-e68, 2012
15342012
The 118 A> G polymorphism in the human µ‐opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease
P Klepstad, TT Rakvåg, S Kaasa, M Holthe, O Dale, PC Borchgrevink, ...
Acta Anaesthesiologica Scandinavica 48 (10), 1232-1239, 2004
4622004
The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients
TT Rakvåg, P Klepstad, C Baar, TM Kvam, O Dale, S Kaasa, HE Krokan, ...
Pain 116 (1-2), 73-78, 2005
4042005
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene
CC Reyes-Gibby, S Shete, T Rakvåg, SV Bhat, F Skorpen, E Bruera, ...
Pain 130 (1-2), 25-30, 2007
3752007
Health care providers underestimate symptom intensities of cancer patients: a multicenter European study
EA Laugsand, MAG Sprangers, K Bjordal, F Skorpen, S Kaasa, ...
Health and quality of life outcomes 8 (1), 1-13, 2010
3682010
The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients
P Klepstad, JH Loge, PC Borchgrevink, TR Mendoza, CS Cleeland, ...
Journal of pain and symptom management 24 (5), 517-525, 2002
3622002
Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients
P Klepstad, T Fladvad, F Skorpen, K Bjordal, A Caraceni, O Dale, ...
Pain 152 (5), 1139-1145, 2011
2302011
Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial
Ø Paulsen, P Klepstad, JH Rosland, N Aass, E Albert, P Fayers, S Kaasa
Journal of clinical oncology 32 (29), 3221-3228, 2014
2122014
Evidence of a role for NMDA receptors in pain perception
P Klepstad, A Maurset, ER Moberg, I Øye
European journal of pharmacology 187 (3), 513-518, 1990
1991990
Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system
BJ Laird, S Kaasa, DC McMillan, MT Fallon, MJ Hjermstad, P Fayers, ...
Clinical Cancer Research 19 (19), 5456-5464, 2013
1942013
Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to …
M Holthe, TN Rakvåg, P Klepstad, JR Idle, S Kaasa, HE Krokan, ...
The pharmacogenomics journal 3 (1), 17-26, 2003
1892003
Genetic Variation in the Catechol-O-Methyltransferase (COMT) Gene and Morphine Requirements in Cancer Patients with Pain
TT Rakvåg, JR Ross, H Sato, F Skorpen, S Kaasa, P Klepstad
Molecular pain 4, 1744-8069-4-64, 2008
1862008
Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network
P Klepstad, S Kaasa, N Cherny, G Hanks, F De Conno, ...
Palliative medicine 19 (6), 477-484, 2005
1862005
Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine …
M Holthe, P Klepstad, K Zahlsen, PC Borchgrevink, L Hagen, O Dale, ...
European journal of clinical pharmacology 58, 353-356, 2002
1702002
Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response
BJA Laird, M Fallon, MJ Hjermstad, S Tuck, S Kaasa, P Klepstad, ...
Journal of Clinical Oncology 34 (23), 2769, 2016
1622016
The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer
BJ Laird, DC McMillan, P Fayers, K Fearon, S Kaasa, MT Fallon, ...
The oncologist 18 (9), 1050-1055, 2013
1562013
Severe head injury: control of physiological variables, organ failure and complications in the intensive care unit
K Schirmer‐Mikalsen, A Vik, SE Gisvold, T Skandsen, H Hynne, ...
Acta Anaesthesiologica Scandinavica 51 (9), 1194-1201, 2007
1402007
Immediate-or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial
P Klepstad, S Kaasa, Å Jystad, B Hval, PC Borchgrevink
Pain 101 (1-2), 193-198, 2003
1362003
for the European Palliative Care Research Collaborative (EPCRC) on behalf of the European Association for Palliative Care (EAPC). Use of opioid analgesics in the treatment of …
A Caraceni, G Hanks, S Kaasa, MI Bennett, C Brunelli, N Cherny, O Dale, ...
Lancet Oncol 13 (2), e58-e68, 2012
1282012
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
TN Andreassen, I Eftedal, P Klepstad, A Davies, K Bjordal, S Lundström, ...
European journal of clinical pharmacology 68, 55-64, 2012
1222012
The system can't perform the operation now. Try again later.
Articles 1–20